Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $310.02 million. The enterprise value is $296.24 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 128.64 million shares outstanding. The number of shares has decreased by -1.08% in one year.
| Current Share Class | 128.64M |
| Shares Outstanding | 128.64M |
| Shares Change (YoY) | -1.08% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 38.53% |
| Owned by Institutions (%) | 46.50% |
| Float | 57.96M |
Valuation Ratios
The trailing PE ratio is 16.07.
| PE Ratio | 16.07 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | 0.64 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 14.80 |
| EV / Sales | 0.53 |
| EV / EBITDA | 3.95 |
| EV / EBIT | 5.25 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.62 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.04% and return on invested capital (ROIC) is 11.35%.
| Return on Equity (ROE) | 9.04% |
| Return on Assets (ROA) | 6.43% |
| Return on Invested Capital (ROIC) | 11.35% |
| Return on Capital Employed (ROCE) | 11.31% |
| Weighted Average Cost of Capital (WACC) | 9.39% |
| Revenue Per Employee | $660,619 |
| Profits Per Employee | $23,445 |
| Employee Count | 854 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 4.93 |
Taxes
In the past 12 months, ORGO has paid $9.94 million in taxes.
| Income Tax | 9.94M |
| Effective Tax Rate | 21.16% |
Stock Price Statistics
The stock price has decreased by -50.61% in the last 52 weeks. The beta is 1.39, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -50.61% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 4.30 |
| Relative Strength Index (RSI) | 22.79 |
| Average Volume (20 Days) | 818,744 |
Short Selling Information
The latest short interest is 12.61 million, so 9.80% of the outstanding shares have been sold short.
| Short Interest | 12.61M |
| Short Previous Month | 13.07M |
| Short % of Shares Out | 9.80% |
| Short % of Float | 21.76% |
| Short Ratio (days to cover) | 21.59 |
Income Statement
In the last 12 months, ORGO had revenue of $564.17 million and earned $20.02 million in profits. Earnings per share was $0.15.
| Revenue | 564.17M |
| Gross Profit | 426.65M |
| Operating Income | 56.39M |
| Pretax Income | 46.97M |
| Net Income | 20.02M |
| EBITDA | 74.98M |
| EBIT | 56.39M |
| Earnings Per Share (EPS) | $0.15 |
Full Income StatementBalance Sheet
The company has $95.92 million in cash and $82.14 million in debt, with a net cash position of $13.79 million or $0.11 per share.
| Cash & Cash Equivalents | 95.92M |
| Total Debt | 82.14M |
| Net Cash | 13.79M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 433.92M |
| Book Value Per Share | 2.36 |
| Working Capital | 262.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.31 million and capital expenditures -$14.15 million, giving a free cash flow of -$24.46 million.
| Operating Cash Flow | -10.31M |
| Capital Expenditures | -14.15M |
| Depreciation & Amortization | 18.60M |
| Net Borrowing | -1.17M |
| Free Cash Flow | -24.46M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
Gross margin is 75.62%, with operating and profit margins of 9.99% and 6.56%.
| Gross Margin | 75.62% |
| Operating Margin | 9.99% |
| Pretax Margin | 8.33% |
| Profit Margin | 6.56% |
| EBITDA Margin | 13.29% |
| EBIT Margin | 9.99% |
| FCF Margin | n/a |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.08% |
| Shareholder Yield | 1.08% |
| Earnings Yield | 6.46% |
| FCF Yield | -7.89% |
Analyst Forecast
The average price target for ORGO is $8.50, which is 252.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 252.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.77 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.77 |
| Piotroski F-Score | 3 |
